ClinConnect ClinConnect Logo
Search / Trial NCT02800122

PAthwAy of Dyspneic patIent in Emergency (PArADIsE)

Launched by CHOUIHED TAHAR · Jun 10, 2016

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Acute Dyspnea Emergency Acute Heart Failure

ClinConnect Summary

The PArADIsE trial is studying how patients with sudden breathing difficulties, known as acute dyspnea, are treated in the emergency department at the CHRU of Nancy hospital. Researchers want to understand the outcomes for these patients after they receive care from the medical team at the hospital. This study is observational, meaning it looks back at the care that has already been provided, rather than providing new treatments.

To participate in this study, you need to be at least 18 years old and have experienced acute dyspnea while being treated by the emergency team at the CHRU of Nancy. However, if you had a serious condition like cardiorespiratory arrest (which is when the heart and breathing stop) before receiving care, you won't be eligible. If you join, you can expect your medical information to be reviewed to help the researchers learn how to improve care for future patients with similar issues. The study is currently recruiting participants, and all genders are welcome to take part.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Man or women ≥ 18 years
  • Patients with acute dyspnea cared by a medical team of the emergencies of CHRU of Nancy.
  • Exclusion Criteria:
  • Cardiorespiratory arrest before the care by a medical team of the emergencies of the CHRU of Nancy.

About Chouihed Tahar

Chouihed Tahar is a dedicated clinical trial sponsor focused on advancing medical research and improving patient outcomes through innovative studies. With a commitment to ethical standards and rigorous scientific methodologies, the organization collaborates with leading healthcare professionals and institutions to facilitate the development of new therapies and treatments. Chouihed Tahar prioritizes patient safety and data integrity, ensuring that all trials are conducted with the utmost care and transparency. Through its expertise and strategic partnerships, the sponsor aims to contribute significantly to the future of healthcare and the well-being of patients globally.

Locations

Nancy, , France

Patients applied

0 patients applied

Trial Officials

Tahar CHOUIHED, MD, PhD

Principal Investigator

Central Hospital, Nancy, France

Nicolas GIRERD, MD

Principal Investigator

Central Hospital, Nancy, France

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials